Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN393855 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Membrane Associated Guanylate Kinase, WW and PDZ Domain Containing 2 (MAGI2) (AA 519-629) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 519-629
- Isotype
- IgG
- Antibody clone number
- 6C8
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Genetic variants that affect length/height in infancy/early childhood in Vietnamese-Korean families.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Deletion of 7q11.21-q11.23 and infantile spasms without deletion of MAGI2.
Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability.
Kim HN, Lee EJ, Jung SC, Lee JY, Chung HW, Kim HL
Journal of human genetics 2010 Oct;55(10):681-90
Journal of human genetics 2010 Oct;55(10):681-90
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR
Molecular medicine (Cambridge, Mass.) 2010 Jul-Aug;16(7-8):247-53
Molecular medicine (Cambridge, Mass.) 2010 Jul-Aug;16(7-8):247-53
Deletion of 7q11.21-q11.23 and infantile spasms without deletion of MAGI2.
Röthlisberger B, Hoigné I, Huber AR, Brunschwiler W, Capone Mori A
American journal of medical genetics. Part A 2010 Feb;152A(2):434-7
American journal of medical genetics. Part A 2010 Feb;152A(2):434-7
Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability.
Wolters VM, Alizadeh BZ, Weijerman ME, Zhernakova A, van Hoogstraten IM, Mearin ML, Wapenaar MC, Wijmenga C, Schreurs MW
Human immunology 2010 Apr;71(4):392-6
Human immunology 2010 Apr;71(4):392-6
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA